Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies
ClinicalTrials.gov study NCT02569476. IPD Sharing: YES. Countries: 3. Publications: 1.
Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
ClinicalTrials.gov study NCT00899353. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma
ClinicalTrials.gov study NCT04836195. IPD Sharing: NO. Countries: 1. Publications: 2.
New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement
ClinicalTrials.gov study NCT02329080. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02703272. IPD Sharing: Not stated. Countries: 20. Publications: 2.
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT00156013. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02285062. IPD Sharing: Not stated. Countries: 21. Publications: 3.
Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT01294579. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03681535. IPD Sharing: NO. Countries: 6. Publications: 1.
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
ClinicalTrials.gov study NCT00910910. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients
ClinicalTrials.gov study NCT01994850. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01555541. IPD Sharing: NO. Countries: 1. Publications: 1.
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00460109. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT02529852. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leuk
ClinicalTrials.gov study NCT02242045. IPD Sharing: YES. Countries: 1. Publications: 1.
Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL
ClinicalTrials.gov study NCT01686165. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00301821. IPD Sharing: Not stated. Countries: 1. Publications: 4.
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
ClinicalTrials.gov study NCT01029366. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03761056. IPD Sharing: NO. Countries: 3. Publications: 2.
A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT03575351. IPD Sharing: Not stated. Countries: 12. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.